Deferred Tax Assets, Operating Loss Carryforwards of CITIUS ONCOLOGY, INC. from 30 Sep 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
CITIUS ONCOLOGY, INC. quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD history and change rate from 30 Sep 2023 to 30 Sep 2025.
  • CITIUS ONCOLOGY, INC. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 30 Sep 2025 was $12,720,000, a 69% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)

CITIUS ONCOLOGY, INC. Quarterly Deferred Tax Assets, Operating Loss Carryforwards (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $12,720,000 +$5,190,000 +69% 30 Sep 2025 10-K 23 Dec 2025 2025 FY
Q3 2024 $7,530,000 +$2,884,000 +62% 30 Sep 2024 10-K 23 Dec 2025 2025 FY
Q3 2023 $4,646,000 30 Sep 2023 10-K 27 Dec 2024 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.